The Venture Codex

Participated · Seed · Nov 2025

Scale Social AI provides an AI-native content infrastructure platform that integrates content capture, rights management, AI-powered evaluation, brand approvals, distribution, and performance measurement into a governed enterprise system. Its platform includes Scout, an AI Director that evaluates submissions against brand standards, campaign objectives, and compliance requirements to build a rights-cleared content library. The company supports consumer-focused enterprise brands across industries including hospitality, food and beverage, retail, experiential marketing, and animal health. Led by CEO Runbin Dong and CTO Paul Greenham, Scale Social AI intends to use newly raised funds to expand its enterprise platform, enhance content intelligence, grow managed programs, and bolster multi-location activation and enterprise approvals. The announcement did not disclose revenue, user metrics, or prior funding details.

Participated · Equity · Mar 2024

mPATH Health develops a digital cancer‑screening program that integrates automation and behavioral science to drive preventive care. The company says its program has demonstrated the ability to double screening rates across diverse populations regardless of race, ethnicity, income, or literacy level. mPATH plans to expand its screening and preventive health modules and to conduct additional rigorous clinical testing supported by grant funding. The platform emphasizes personalized outreach to identify, educate, and ensure timely access to relevant screenings, with a stated commitment to health equity. The recent funding is intended to accelerate growth, expand reach, and document return on investment for health systems and insurers. mPATH Health integrates automation and behavioral science to improve preventive cancer screening. Led by CEO and Founder Dr. Dave Miller, the company uses plain language, engaging animations, and video testimonials to inform, motivate, and empower individuals to request and complete evidence-based screenings. mPATH is currently in use across three healthcare systems in North Carolina for colorectal and lung cancer screening, and a fourth major healthcare system will launch the program in March. The company raised $1.1M consisting of $706K in angel investments and $400K from a National Cancer Institute Small Business Technology Transfer grant. mPATH plans to use the funds to develop new modules for other preventive care needs, add artificial intelligence to guide its outreach, and accelerate its growth trajectory.